-
Taxonomy & unit
-
dei: shares
-
Description
-
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
-
Summary
-
Adaptimmune Therapeutics PLC quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2016 to Q2 2024.
- Adaptimmune Therapeutics PLC Entity Common Stock, Shares Outstanding for the quarter ending August 8, 2024 was 1.53B shares, a 13.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)